Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Tissue Regenix Group (TRX) Share Price

Price 32.00p on 27-05-2025 at 17:30:18
Change 0.90p 2.89%
Buy 33.00p
Sell 31.00p
Buy / Sell TRX Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Buy 488.00 at 32.15p
Day's Volume: 24,534
Last Close: 32.00p
Open: 32.00p
ISIN: GB00BNTXR104
Day's Range 32.00p - 32.00p
52wk Range: 31.00p - 74.00p
Market Capitalisation: £23m
VWAP: 32.12512p
Shares in Issue: 71m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Tissue Regenix Group (TRX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 488 32.15p Ordinary
 15:45:19 - 27-May-25
Buy* 2,410 32.15p Ordinary
 15:43:55 - 27-May-25
Buy* 1,072 32.175p Ordinary
 15:37:17 - 27-May-25
Buy* 5,000 32.15p Ordinary
 15:25:43 - 27-May-25
Sell* 15 31.02p Ordinary
 14:49:10 - 27-May-25
Sell* 549 31.02p Ordinary
 09:32:00 - 27-May-25
Buy* 15,000 32.15p Ordinary
 08:18:55 - 27-May-25
Buy* 2,000 32.18p Ordinary
 14:32:39 - 23-May-25
Sell* 1,000 31.02p Ordinary
 08:52:37 - 23-May-25
Sell* 856 31.02p Ordinary
 11:06:12 - 22-May-25
See more Tissue Regenix Group trades

Tissue Regenix Group (TRX) Share Price History

Time period:
to
Date Open High Low Close Volume
27th May 2025 (Tue) 32.00 32.00 32.00 32.00 24,534
26th May 2025 (Mon) 31.10 31.10 31.10 31.10 0
23rd May 2025 (Fri) 32.00 32.00 32.00 32.00 11,000
22nd May 2025 (Thu) 32.00 32.00 32.00 32.00 6,972
21st May 2025 (Wed) 32.50 32.50 32.00 32.00 38,465
20th May 2025 (Tue) 32.50 32.50 32.50 32.50 59,650
19th May 2025 (Mon) 32.50 33.00 32.50 32.50 15,100
16th May 2025 (Fri) 32.50 32.50 32.50 32.50 31,690
15th May 2025 (Thu) 32.50 32.50 32.50 32.50 1,706
14th May 2025 (Wed) 32.50 32.50 32.50 32.50 1,857
13th May 2025 (Tue) 32.50 32.50 32.50 32.50 2,297
12th May 2025 (Mon) 32.50 32.50 32.50 32.50 15,524
9th May 2025 (Fri) 32.00 32.50 32.00 32.50 5,410
8th May 2025 (Thu) 32.50 32.50 32.50 32.50 15,790
7th May 2025 (Wed) 32.50 32.50 32.50 32.50 2,626
6th May 2025 (Tue) 32.50 33.00 32.40 32.50 17,733
5th May 2025 (Mon) 32.80 32.80 32.80 32.80 0
2nd May 2025 (Fri) 32.00 32.80 32.00 32.80 139,611
1st May 2025 (Thu) 34.00 31.00 31.00 31.00 12,250
30th Apr 2025 (Wed) 34.00 34.00 33.20 33.20 8,329
29th Apr 2025 (Tue) 35.00 34.50 34.00 34.00 65,208
28th Apr 2025 (Mon) 35.00 35.00 34.20 35.00 17,343
See more Tissue Regenix Group price history

Tissue Regenix Group (TRX) Regulatory News

Date Source Headline
24th Apr 2025 9:38 am RNS Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc
15th Apr 2025 9:23 am RNS Form 8.5 (EPT/NON-RI)
10th Apr 2025 9:09 am RNS Form 8.5 (EPT/NON-RI)
9th Apr 2025 10:45 am RNS Form 8.5 (EPT/NON-RI)
8th Apr 2025 7:00 am RNS Conclusion of Strategic Review & Offer Period
7th Apr 2025 8:46 am RNS Form 8.5 (EPT/NON-RI)
1st Apr 2025 9:12 am RNS Form 8.5 (EPT/NON-RI)
31st Mar 2025 9:21 am RNS Form 8.5 (EPT/NON-RI)
27th Mar 2025 7:00 am RNS European patent granted
25th Mar 2025 8:58 am RNS Form 8.5- Tissue Regenix Group Plc
See more Tissue Regenix Group regulatory news

Tissue Regenix Group (TRX) Share News

IN BRIEF: Tissue Regenix granted European patent for dCELL

27th Mar 2025 20:17

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Says European Patent Office grants European patent (EP4114476) for its decellularisation technology, dCELL. The patent relates to the method for producing decellularisation tissue scaffold which is a foundation for Tissue Regenix's platform and plays a pivotal role in the development of its product range. This patent adds to those the company already has granted in the US and UK for dCELL. Read More

IN BRIEF: Tissue Regenix eyes profit beat; plots German jv disposal

31st Jan 2025 21:30

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - Revenue increases 8% to USD28.4 million in the year ending December 31 from USD26.3 million a year prior. In addition, expects to report an adjusted earnings before interest, tax, depreciation and amortisation above expectations. Notes this will mark the second full year of profitability for Tissue Regenix and the fourth year of above-market growth. Read More

IN BRIEF: Tissue Regenix contacts firms as it considers possible sale

4th Nov 2024 18:21

Tissue Regenix Group PLC - Leeds, England-based regenerative medical devices company - In response to press reports, say that it is conducting a review of strategic options, which may include soliciting offers for Tissue Regenix. Accordingly, the firm has contacted a limited number of potential counterparties to assess whether they could put forward a proposal "that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy". Says it has not received any indicative non-binding proposals to date, and says there can be no certainty any offer will be made. Read More

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

10th Sep 2024 21:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

3rd Sep 2024 11:31

Read More

See more Tissue Regenix Group news
FTSE 100 Latest
Value8,778.05
Change60.08

Login to your account

Forgot Password?

Not Registered